New nerve block could cut opioid use after heart surgery

NCT ID NCT07164677

Recruiting now Symptom relief Sponsor: Ondokuz Mayıs University Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jul 02, 2026 · Updated 1 time

Summary

This study tests whether a specific nerve block (SPSIP block) can reduce pain and the need for strong painkillers after open-heart surgery. Fifty adults having elective surgery will receive either the block plus standard pain care or standard care alone. Researchers will measure pain scores and total opioid use in the first 24 hours after surgery.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: bupivacaine (a local anesthetic) given as a nerve block
What this could lead to: If it works, this nerve block could become a standard way to manage pain after open-heart surgery, reducing the need for strong opioids.
What could go wrong: This is a small, early-stage trial with only 50 people, so results may not apply to everyone. The block may not provide significant pain relief or could cause side effects like bruising or infection.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CARDIAC SURGERY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Pain, Postoperative

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CARDIAC SURGERY POST OPERATIVE PAIN, ACUTE

Contacts and locations

Locations

Burhan Dost
RECRUITING

Samsun, 55270, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.